Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate.
about
Isolated CNS Blast Crises in Chronic Myeloid Leukaemia Presenting as Hypertrophic Pachymeningitis and Bilateral Optic Neuritis: A Case ReportBeyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphomac-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.Three paths to better tyrosine kinase inhibition behind the blood-brain barrier in treating chronic myelogenous leukemia and glioblastoma with imatinibDasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case reportIsolated central nervous system relapse in chronic myeloid leukemiaExtramedullary Involvement by Chronic Myelogeneous Leukemia in Five Patients With Unusual Clinicopathologic Features: A Review of the Effectiveness of Tyrosine Kinase InhibitorsA case of isolated lymphoblastic relapse of the central nervous system in a patient with chronic myelogenous leukemia treated with imatinib.Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature.An Atypical Initial Presentation of Chronic Myeloid Leukemia with Central Nervous System and Lymph Node Blast CrisesImproving imatinib delivery to central nervous system.Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia.Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid.Different clonal dynamics of chronic myeloid leukaemia between bone marrow and the central nervous system.Taming of the shrew--overcoming extramedullary blast crisis in the era of the new tyrosine kinase inhibitors.
P2860
Q26764774-F56A1252-6125-4337-9EB9-2AA715A0B7EEQ27013785-7107A019-DA18-4444-8616-B9CE090E55BDQ31104448-E32C4015-286E-459B-8C6F-2E34E81D8280Q33655352-B6EE86E7-B338-4985-A855-27A40BE249C4Q35167824-0D3A7218-558C-4A6E-873E-2AC4ECF18C17Q35279056-6B29FB89-7F9C-410B-B9D1-2726F3AE7173Q36856998-B4C143E4-757A-47C4-89C1-B9DDF4040762Q37722753-93167410-E701-43B9-A576-74596FCDBC23Q38714657-42165EDC-E6B5-4E60-B3D9-8176E6686412Q41236236-3184908C-C9E3-4249-AAE2-CBB426AEBFABQ43042596-C5A5121C-8D1C-4444-A82B-E473F1150335Q45395361-64F72E02-49D1-4E1C-A707-76EF604CCD81Q48274819-3C46FE7D-CEDD-4F4D-9F52-B363850059EBQ48371840-730A7DA6-FC7C-435D-B97E-FB44D3204191Q54440145-20FADEF8-4B53-485D-9D55-A13D9DA8C8AD
P2860
Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Central nervous system is a sa ...... reated with imatinib mesylate.
@en
Central nervous system is a sa ...... reated with imatinib mesylate.
@nl
type
label
Central nervous system is a sa ...... reated with imatinib mesylate.
@en
Central nervous system is a sa ...... reated with imatinib mesylate.
@nl
prefLabel
Central nervous system is a sa ...... reated with imatinib mesylate.
@en
Central nervous system is a sa ...... reated with imatinib mesylate.
@nl
P2093
P2860
P1476
Central nervous system is a sa ...... reated with imatinib mesylate.
@en
P2093
P2860
P304
P356
10.1111/J.1445-5994.2009.01947.X
P577
2009-06-01T00:00:00Z